Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
17 results
- 1/2상모집 중단 (진행 중)· MelanomaA Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
리드: GSK
- 1/2상모집 중단 (진행 중)· Recurrent Vulvovaginal CandidiasisAssessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
협력: GSK
- 1/2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaTwo-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
협력: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
리드: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaNovel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
협력: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
리드: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaStudy of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
협력: 암젠, GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaBlmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
협력: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM
리드: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM
리드: GSK
- 1/2상모집 중단 (진행 중)· Relapsed and/or Refractory Multiple MyelomaMulti-Center Study of GSK2857916 in Combination With Pomalidomide and Dex
협력: GSK
- 1/2상모집 중단 (진행 중)· Glioblastoma MultiformePhase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
협력: GSK
- 1/2상모집 중단 (진행 중)· Clear Cell Renal Cell CarcinomaPazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
협력: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.